BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
日曜日, 9 27

Minimed Group Inc

MMEDNASDAQ
Trade with Public
Trade with Public
$19.98
-0.46-2.25%
近くで: Sep 25, 5:00 PM EST
$19.98
N/A
時間外: Sep 25, 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント比較オプション株式レポート

Minimed Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Minimed Group (MMED).

Price Target Range — 3 Quarters

Analyst Consensus — 13 Analysts

12Buy
1Hold
Consensus RatingBuy# Analysts13Avg. Consensus PT$25Upside to Avg. PT+25.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →
DateFirmAnalystActionRating ChangePrice Target
Sep 24, 2026Truist SecuritiesRichard NewitterInitiateBuy$29
Sep 3, 2026Morgan StanleyKallum TitchmarshPT RaiseOverweight$19→$21
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.
Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27

Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Minimed Group, Raises Price Target to $26

Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $22 to $26.
Benzinga Newsdesk

These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results

MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
Avi Kapoor

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved